1-7 of 7
Amit Aggarwal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Best Overall Response–Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE

Jiangang Liu, David S. Moura, Robin L. Jones, Amit Aggarwal, Philip J. Ebert, Andrew J. Wagner, Jennifer Wright, Javier Martin-Broto, William D. Tap
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (11): 2598–2608.
https://doi.org/10.1158/1078-0432.CCR-23-3936
Published: 03 June 2024
View article titled, Best Overall Response–Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE
Open the PDF for Best Overall Response–Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE in another window
Includes: Supplementary data
Journal Articles

Correction: Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

Alyssa C. Flint, Dana K. Mitchell, Steven P. Angus, Abbi E. Smith, Waylan Bessler, Li Jiang, Henry Mang, Xiaohong Li, Qingbo Lu, Brooke Rodriguez, George E. Sandusky, Andi R. Masters, Chi Zhang, Pengtao Dang, Jenna Koenig, Gary L. Johnson, Weihua Shen, Jiangang Liu, Amit Aggarwal, Gregory P. Donoho, Melinda D. Willard, Shripad V. Bhagwat, D. Wade Clapp, Steven D. Rhodes
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (9): 1992.
https://doi.org/10.1158/1078-0432.CCR-24-0635
Published: 01 May 2024
View article titled, Correction: Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
Open the PDF for Correction: Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma in another window
Journal Articles

Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

Alyssa C. Flint, Dana K. Mitchell, Steven P. Angus, Abbi E. Smith, Waylan Bessler, Li Jiang, Henry Mang, Xiaohong Li, Qingbo Lu, Brooke Rodriguez, George E. Sandusky, Andi R. Masters, Chi Zhang, Pengtao Dang, Jenna Koenig, Gary L. Johnson, Weihua Shen, Jiangang Liu, Amit Aggarwal, Gregory P. Donoho, Melinda D. Willard, Shripad V. Bhagwat, D. Wade Clapp, Steven D. Rhodes
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (17): 3438–3456.
https://doi.org/10.1158/1078-0432.CCR-22-2854
Published: 01 September 2023
View article titled, Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
Open the PDF for Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma in another window
Includes: Supplementary data
Journal Articles

Clinical and Genomic Characteristics of Patients with Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer Following Progression on Cyclin-Dependent Kinase 4 and 6 Inhibitors

Xi Rao, Yongmei Chen, Julie Beyrer, Emily Nash Smyth, Claudia Morato Guimaraes, Lacey M. Litchfield, Lee Bowman, Garreth W. Lawrence, Amit Aggarwal, Fabrice Andre
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (17): 3372–3383.
https://doi.org/10.1158/1078-0432.CCR-22-3843
Published: 01 September 2023
View article titled, Clinical and Genomic Characteristics of Patients with Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer Following Progression on Cyclin-Dependent Kinase 4 and 6 Inhibitors
Open the PDF for Clinical and Genomic Characteristics of Patients with Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer Following Progression on Cyclin-Dependent Kinase 4 and 6 Inhibitors in another window
Includes: Supplementary data
Journal Articles

Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR+/HER2− Breast Cancer

Sara A. Hurvitz, Miguel Martin, Michael F. Press, David Chan, María Fernandez-Abad, Edgar Petru, Regan Rostorfer, Valentina Guarneri, Chiun-Sheng Huang, Susana Barriga, Sameera Wijayawardana, Manisha Brahmachary, Philip J. Ebert, Anwar Hossain, Jiangang Liu, Adam Abel, Amit Aggarwal, Valerie M. Jansen, Dennis J. Slamon
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (3): 566–580.
https://doi.org/10.1158/1078-0432.CCR-19-1425
Published: 03 February 2020
View article titled, Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR<sup>+</sup>/HER2<sup>−</sup> Breast Cancer
Open the PDF for Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR<sup>+</sup>/HER2<sup>−</sup> Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Mouse PDX Trial Suggests Synergy of Concurrent Inhibition of RAF and EGFR in Colorectal Cancer with BRAF or KRAS Mutations

Yung-mae M. Yao, Gregory P. Donoho, Philip W. Iversen, Youyan Zhang, Robert D. Van Horn, Amelie Forest, Ruslan D. Novosiadly, Yue Wang Webster, Philip Ebert, Steven Bray, Jason C. Ting, Amit Aggarwal, James R. Henry, Ramon V. Tiu, Gregory D. Plowman, Sheng-Bin Peng
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (18): 5547–5560.
https://doi.org/10.1158/1078-0432.CCR-16-3250
Published: 14 September 2017
View article titled, Mouse PDX Trial Suggests Synergy of Concurrent Inhibition of RAF and EGFR in Colorectal Cancer with <em>BRAF</em> or <em>KRAS</em> Mutations
Open the PDF for Mouse PDX Trial Suggests Synergy of Concurrent Inhibition of RAF and EGFR in Colorectal Cancer with <em>BRAF</em> or <em>KRAS</em> Mutations in another window
Includes: Supplementary data
Journal Articles

Feasibility of Using Low-Volume Tissue Samples for Gene Expression Profiling of Advanced Non-Small Cell Lung Cancers

Elaine H. Lim, Amit Aggarwal, Thirugananam Agasthian, Poo-Sing Wong, Christie Tan, Eugene Sim, Lenny Tan, Poh-Sun Goh, Shih-Chang Wang, Kay-Leong Khoo, Amartya Mukherjee, See-Meng Khoo, Gerald Chua, Barbro Nilsson, Kang-Hoe Lee, Patrick Tan
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (16): 5980–5987.
Published: 15 December 2003
View article titled, Feasibility of Using Low-Volume Tissue Samples for Gene Expression Profiling of Advanced Non-Small Cell Lung Cancers
Open the PDF for Feasibility of Using Low-Volume Tissue Samples for Gene Expression Profiling of Advanced Non-Small Cell Lung Cancers in another window